Jackson Creek Investment Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Jackson Creek Investment Advisors’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-38,846	Closed	-$1.8M	–	313
2025 Q4	$1.8M	Buy	38,846 +28,170	+264%	+$1.18M	0.53%	60
2025 Q3	$374K	Sell	10,676 -18	-0.2%	-$626	0.11%	245
2025 Q2	$316K	Sell	10,694 -28,988	-73%	-$827K	0.09%	290
2025 Q1	$1.19M	Sell	39,682 -22	-0.1%	-$672	0.38%	146
2024 Q4	$1.14M	Sell	39,704 -1,232	-3%	-$40.8K	0.34%	153
2024 Q3	$1.58M	Buy	+40,936	New	+$1.46M	0.47%	89
2024 Q2	–	Sell	-30,714	Closed	-$1.19M	–	312
2024 Q1	$1.19M	Buy	+30,714	New	+$1.07M	0.43%	66
2021 Q2	–	Sell	-46,575	Closed	-$1.1M	–	311
2021 Q1	$1.1M	Sell	46,575 -1,383	-3%	-$32.9K	0.38%	120
2020 Q4	$961K	Sell	47,958 -82	-0.2%	-$1.6K	0.38%	131
2020 Q3	$1M	Buy	+48,040	New	+$867K	0.45%	45

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Jackson Creek Investment Advisors's COLL Position: Q1 2026 in Review

Jackson Creek Investment Advisors sold out of Collegium Pharmaceutical (COLL) in Q1 2026, closing a stake of 38,846 shares — an estimated $1.8M sold.

Jackson Creek Investment Advisors first reported a position in COLL in Q3 2020 and held it in 10 quarters. The position peaked at $1.8M in Q4 2025. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

Jackson Creek Investment Advisors reported no remaining Collegium Pharmaceutical position as of Q1 2026 after selling out during the quarter.
Jackson Creek Investment Advisors sold 38,846 Collegium Pharmaceutical shares in Q1 2026, an estimated $1.8M.
Jackson Creek Investment Advisors first reported a position in Collegium Pharmaceutical in Q3 2020 and held it in 10 quarters.
Jackson Creek Investment Advisors's Collegium Pharmaceutical position peaked at $1.8M in Q4 2025.
266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Jackson Creek Investment Advisors's 13F filing for Q1 2026, filed 5 May 2026.